Spotlight
Video

ESMO 2010 - Dr. Ross Camidge, MD discusses Clinical Activity of Crizotinib (PF-02341066), in ALK-Positive Patients with Non-Small Cell Lung Cancer (NSCLC)

Loading........
Description: Dr. Ross Camidge, MD discusses Clinical Activity of Crizotinib (PF-02341066), in ALK-Positive Patients with Non-Small Cell Lung Cancer (NSCLC)
Shared By : europe_meeting_2010
Posted on : 10/10/10
Added : 6 years ago



More From europe_meeting_2010

Nothing found.